GAIN THERAPEUTICS, INC (GANX) Net margin 2021–2024
GAIN THERAPEUTICS, INC (GANX) net profit margin by fiscal year — reported net income divided by reported revenue.
-36990.2%FY2024 · since FY2021: -48096.0% → -36990.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -36990.2% | -20202.3 pp |
| FY2023 | -16787.9% | -3653.5 pp |
| FY2022 | -13134.5% | +34961.5 pp |
| FY2021 | -48096.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More GANX financial trends
GANX RevenueGANX Net incomeGANX Gross profitGANX Gross marginGANX Operating incomeGANX Operating marginGANX Operating cash flowGANX Free cash flowGANX Capital expendituresGANX Return on equityGANX Stock buybacksGANX Dividends paidGANX Total assetsGANX Total liabilitiesGANX Shareholders’ equityGANX overview →